Lung transplantation in cystic fibrosis. Patient selection criteria

被引:0
|
作者
Stern, M [1 ]
Reynaud-Gaubert, M [1 ]
Haloun, A [1 ]
Bertocchi, M [1 ]
Grenet, D [1 ]
机构
[1] Hop Foch, Grp Transplantat Pulm, F-92151 Suresnes, France
关键词
cystic fibrosis; adult; lung transplantation;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Lung transplantation (LT) became during the ten past years an important therapeutic option for cystic fibrosis adult patients with end-stage chronic lung disease. LT clearly improves both survival and long term quality of life. A rigorous selection of the candidates is of paramount importance to improve the results of LT because of the lack of shortage of organs. This selection requires a multidisciplinary assessment to refuse patients with absolute exclusion criteria or general medical conditions that impact negatively on short- and long-term outcome. One of the major difficulties is to determine the best rime to refer patients to transplantation, arguing the comparison between the predicted survival time of the candidate, under optimal medical therapy, with or without LT The selection period is also an active process to prepare the patients to the postoperative follow-up and includes a nutritional and rehabilitation program with an educational and psychological preparation. The aim of the present work is to gather the worldwide principles of the selection of the CF patients for LT commonly used by the LT centers. These recommendations should provide the CF center practitioners with the main elements to prepare their patients to an LT project before a relentless end-stage clinical condition.
引用
收藏
页码:779 / 784
页数:6
相关论文
共 50 条
  • [21] Decontamination and Lung Transplantation of a Patient With Cystic Fibrosis With Resistant Infections
    Shah, Aakash
    Pasrija, Chetan
    Boulos, Francesca
    Pham, Si
    Griffith, Bartley P.
    Amoroso, Anthony
    Sanchez, Pablo G.
    Kon, Zachary N.
    ANNALS OF THORACIC SURGERY, 2019, 107 (04): : E239 - E241
  • [22] Airway Dehiscence After Lung Transplantation in a Patient With Cystic Fibrosis
    Hayes, Don, Jr.
    Hatton, Kevin W.
    Feola, David J.
    Murphy, Brian S.
    Mullett, Timothy W.
    RESPIRATORY CARE, 2010, 55 (12) : 1746 - 1750
  • [23] Pharmacogenetics and cystic fibrosis.
    不详
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2005, 35 (02): : 206 - 206
  • [24] The liver in cystic fibrosis.
    Lacaille, F
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1997, 21 (8-9): : 607 - 618
  • [25] Lung transplantation for cystic fibrosis
    Irani, Sarosh
    Hofer, Markus
    Boehler, Annette
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2007, 2 (01): : 88 - 92
  • [26] Lung transplantation for cystic fibrosis
    Liou, Theodore G.
    Woo, Marlyn S.
    Cahill, Barbara C.
    CURRENT OPINION IN PULMONARY MEDICINE, 2006, 12 (06) : 459 - 463
  • [27] Lung Transplantation in Cystic Fibrosis
    Rosenblatt, Randall L.
    RESPIRATORY CARE, 2009, 54 (06) : 777 - 786
  • [28] Lung transplantation for cystic fibrosis
    Corris, Paul A.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2008, 13 (05) : 484 - 488
  • [29] LUNG TRANSPLANTATION IN CYSTIC FIBROSIS
    Garrity, Edward R.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S124 - S124
  • [30] Autoantibodies in Cystic Fibrosis.
    Low, T. B.
    Greene, C. M.
    O'Neill, S. J.
    McElvaney, N. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179